Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of
anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the
treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or
ocular hypertension.